UK markets closed

Gossamer Bio, Inc. (GOSS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1800+0.0100 (+0.85%)
At close: 04:00PM EDT
1.1609 -0.02 (-1.62%)
After hours: 07:14PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 265.06M
Enterprise value 181.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.22
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.12

Trading information

Stock price history

Beta (5Y monthly) 1.72
52-week change 3-6.35%
S&P500 52-week change 327.86%
52-week high 31.8800
52-week low 30.4530
50-day moving average 31.1353
200-day moving average 31.0164

Share statistics

Avg vol (3-month) 31.1M
Avg vol (10-day) 31.32M
Shares outstanding 5225.58M
Implied shares outstanding 6225.58M
Float 8191M
% held by insiders 12.26%
% held by institutions 193.30%
Shares short (15 Mar 2024) 411.09M
Short ratio (15 Mar 2024) 46.54
Short % of float (15 Mar 2024) 45.77%
Short % of shares outstanding (15 Mar 2024) 44.91%
Shares short (prior month 15 Feb 2024) 415.3M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-37.17%
Return on equity (ttm)-480.50%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -172.15M
Net income avi to common (ttm)-179.82M
Diluted EPS (ttm)-1.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)296.42M
Total cash per share (mrq)1.31
Total debt (mrq)212.46M
Total debt/equity (mrq)338.49%
Current ratio (mrq)5.94
Book value per share (mrq)0.28

Cash flow statement

Operating cash flow (ttm)-159.16M
Levered free cash flow (ttm)-84.66M